What's breaking now, across thousands of outlets.
A Russian attack on Kyiv on Oct. 19 damaged the Consultative and Diagnostic Center at Kyiv City Clinical Hospital No. 6 in the Solomianskyi district, forcing it to suspend operations, the Kyiv City Health Department reported.
We haven't written up this one. New Voice of Ukraine has the full story — the link below goes straight to it.
KUALA LUMPUR – As scientists, economists, financiers, and policymakers gathered to discuss the impact of climate at the Global Tipping Points conference last week, the air quality in the Malaysian…
NAIROBI, Kenya, Oct 19 — The Intergovernmental Authority on Development (IGAD) is stepping up regional efforts to detect animal disease outbreaks before they spread to humans, through a new…
A research team led by senior researcher Minyoung Lee and principal researcher Sunggyu Park of the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science…
Michael Lynch, from Men's Action Network (MAN) offered to meet the Derry City footballer James McClean.
Germany's Merck KGaA agreed to buy UK drug developer Silence Therapeutics for $1.3 billion, building out its work in rare and specialty diseases using genetic medicines.
The acquisition gives the German company a promising blood disorder medicine that passed a Phase 2 test and could threaten a Takeda drug.
